Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
746 AFM24 and atezolizumab combination in patients with advanced epidermal growth factor receptor-expressing (EGFR+) solid tumors: Initial results from the phase 1 dose-escalation study
Compose a Response to This Article
Other responses
No responses have been published for this article.